Login / Signup

Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study.

Kazutaka UchidaShinichiro UedaFumihiro SakakibaraNorito KinjoMari NezuHideki AraiTakeshi Morimoto
Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2022)
Statins significantly reduced the risk of major bleeding, all-cause mortality, and ischemic events in patients with NVAF taking OACs. Their additive benefits should be considered in routine practice and thus be further researched.
Keyphrases